Product
AI AGENTS
AI APPLICATIONS
OTHERS
Solutions
INDUSTRIES
Pricing
Resources
EXPLORE
ENGAGE
SUPPORT & SERVICES
About
PatSnap Eureka Platform
Agents for IP
Agents for Engineering
Agents for Life Sciences
Agents for Materials
Analytics
IP IntelligenceSynapse
Biopharma IntelligenceBio
Biosequence Search and AnalysisChemical
Chemical Structure Search and AnalysisEureka AI Inside
Professional Services
Customer Stories
Blog
Global Innovation Report
Glossary
Newsroom
Webinars & Training
Frontier
User Community
Trust and Security
PatentBench
LLM
Help center
Careers
Access to over 2,000,000,000 structured data points around patents, science, litigation, and tech sectors
Innovate 75% faster at 25% less cost
Cloud or on-prem for maximum privacy and control
Trusted by more than 18,000 innovators worldwide
To use , click the vertification button in the email we sent to [email protected].
This helps keep your account secure.
You should receive it shortly. Don’t forget to check your spam folder.
Unlock professional features and history
Already have an account? Log In
To start using PatSnap Eureka, click the verification button in the email we sent to .
This helps keep your account secure.
Haven't received it? Check your spam folder.
Thoughtfully curated series offering valuable insights for innovation professionals
Article | Report Silicone, DLC, sol-gel ceramics, bio-based polymers, and plasma films mapped against PFAS performance benchmarks and 2025–2027 regulatory deadlines.
Article | Report How to design high-entropy alloy compositions with simultaneous high strength and ductility—covering ML-driven screening, CALPHAD phase prediction, and thermomechanical processing.
Article | Report China controls ~90% of rare earth processing and ~85% of NdFeB magnet output. Discover how export controls, cerium alternatives, and Western capacity buildouts are reshaping the global magnet supply chain.
Article | Report How to engineer LFP cathode composition and particle morphology to simultaneously improve cycle life, rate performance, and thermal stability for EV batteries.
Article | Report How do Sacituzumab Govitecan, Datopotamab Deruxtecan, and Trastuzumab Deruxtecan differ in TNBC? A deep-dive into target biology, bystander killing, and resistance.
Article | Report Thermo Fisher leads mass spectrometry with 341 patents; Danaher counters with 377 across subsidiaries. Explore divergent R&D strategies shaping life science instruments 2015–2026.
Article | Report Bimekizumab vs secukinumab: head-to-head trial data, patent evidence, and mechanistic rationale for dual IL-17A/F blockade across psoriasis, axSpA, and HS.
Article | Report How selective androgen receptor degraders (SARDs) use the ubiquitin-proteasome system to overcome LBD mutations and AR-V7 splice variants driving mCRPC resistance.
Article | Report Deep analysis of Novartis patent WO2015009616A1: Iptacopan Factor B inhibitor binding pocket interactions, selectivity SAR, ADME/PK, and piperidine vs pyrrolidine scaffold comparison.
Article | Report LK-99 debunked, hydride systems hitting 556K, and zero ambient-pressure candidates validated. The room-temperature superconductor landscape in 2026, fully mapped.
Article | Report Patent CN115485277B reveals Zongertinib's 133× HER2/EGFR selectivity, cysteine engagement strategy, and 19 lead compounds with sub-nanomolar IC50 values.
Article | Report CagriSema (amylin/GLP-1) vs. Tirzepatide (GIP/GLP-1): mechanistic differences, clinical trial data, weight loss outcomes, and cardiometabolic profiles compared.
Article | Report How Micron's 621 HBM patents and SK Hynix's 50% market share define the HBM2E-to-HBM4 race. Deep-dive patent strategy, DRAM architecture, and 2026 outlook.
Article | Report Deep analysis of WO2019044947A1: T-DXd GGFG linker chemistry, DXd payload conjugation, DAR 7-8 optimization, and how these structural innovations widen the therapeutic index vs. T-DM1.
Article | Report How CNS-penetrant BTK inhibitors tolebrutinib and fenebrutinib target smoldering neuroinflammation differently from anti-CD20 therapies in MS.